NAMS Menopause Certification Exam Prep
2025/2026 | Comprehensive Practice Questions,
Study Guide, and Test Bank with Detailed
Rationales | Certified Menopause Practitioner
(NCMP) Review for Healthcare Professionals
1. What is the primary hormone that declines during menopause?
(A) Progesterone
(B) Estrogen
(C) Testosterone
(D) Luteinizing hormone
Rationale: Estrogen levels significantly decline during menopause, leading to
many of the symptoms associated with this transition.
2. Which of the following is a common symptom of menopause?
(A) Increased energy
(B) Hot flashes
(C) Weight loss
(D) Improved mood
Rationale: Hot flashes are a prevalent symptom experienced by many women
during menopause due to hormonal changes.
3. What is the average age of onset for menopause in women?
(A) 40
(B) 51
(C) 55
(D) 60
Rationale: The average age of menopause onset is around 51, though it can vary
from 45 to 55.
4. Which lifestyle change is recommended to manage menopausal symptoms?
(A) Increased caffeine intake
(B) Regular exercise
(C) High-fat diet
(D) Smoking cessation
Rationale: Regular exercise can help alleviate symptoms such as mood swings
and hot flashes and improve overall health.
,5. What type of therapy is often used to treat menopausal symptoms?
(A) Hormone Replacement Therapy (HRT)
(B) Antidepressants
(C) Antihistamines
(D) Antibiotics
Rationale: Hormone Replacement Therapy is a common treatment to alleviate
symptoms caused by estrogen deficiency.
6. Which of the following is a potential risk of long-term hormone replacement
therapy?
(A) Osteoporosis
(B) Breast cancer
(C) Heart disease
(D) Thyroid disorders
Rationale: Long-term use of HRT, especially combined estrogen and progestin,
has been associated with an increased risk of breast cancer.
7. What is a common non-hormonal treatment for hot flashes?
(A) Selective serotonin reuptake inhibitors (SSRIs)
(B) Beta-blockers
(C) Benzodiazepines
(D) Antihistamines
Rationale: SSRIs have been found to help reduce the frequency and severity of
hot flashes in some women.
8. Which dietary change can help manage menopausal symptoms?
(A) Increased sugar intake
(B) Increased calcium and vitamin D
(C) High caffeine consumption
(D) Low-carbohydrate diet
Rationale: Increasing calcium and vitamin D intake is crucial for bone health,
especially post-menopause, to prevent osteoporosis.
9. What is the term used to describe the time leading up to menopause?
(A) Postmenopause
(B) Perimenopause
(C) Premenopause
(D) Menopause transition
Rationale: Perimenopause refers to the transitional period leading up to
menopause, marked by hormonal fluctuations.
,10. What is a potential benefit of hormone replacement therapy?
(A) Increased risk of heart disease
(B) Relief from menopausal symptoms
(C) Weight gain
(D) Increased risk of stroke
Rationale: HRT can provide significant relief from menopausal symptoms such
as hot flashes and vaginal dryness.
11. What is the effect of menopause on bone density?
(A) Increased density
(B) Decreased density
(C) No effect
(D) Stabilized density
Rationale: The decline in estrogen levels during menopause leads to decreased
bone density, increasing the risk of osteoporosis.
12. Which of the following is a psychosocial issue that may arise during
menopause?
(A) Mood swings
(B) Improved self-esteem
(C) Increased social activity
(D) Decreased stress levels
Rationale: Many women experience mood swings and emotional changes due to
hormonal fluctuations during menopause.
13. Which of the following factors can influence the onset of menopause?
(A) Genetic predisposition
(B) Smoking
(C) All of the above
(D) None of the above
Rationale: Both genetic factors and lifestyle choices such as smoking can
influence the timing of menopause.
14. What is the primary goal of menopause management?
(A) Symptom relief
(B) Hormonal balancing
(C) Weight loss
(D) Increased libido
, Rationale: The primary goal is to relieve menopausal symptoms to improve
quality of life.
15. Which symptom is associated with decreased estrogen levels?
(A) Vaginal dryness
(B) Increased libido
(C) Improved mood
(D) Increased energy
Rationale: Decreased estrogen can lead to vaginal dryness, a common issue
during menopause.
16. What is a common urinary symptom experienced during menopause?
(A) Increased frequency
(B) Urinary incontinence
(C) Decreased frequency
(D) Painful urination
Rationale: Hormonal changes can lead to urinary incontinence, which is
common during menopause.
17. Which of the following is a potential consequence of untreated menopausal
symptoms?
(A) Improved quality of life
(B) Decreased quality of life
(C) Increased social interaction
(D) Enhanced productivity
Rationale: Untreated symptoms can lead to a lowered quality of life due to
discomfort and emotional distress.
18. What is the role of phytoestrogens in menopause management?
(A) Increase estrogen levels
(B) Mimic estrogenic activity
(C) Decrease bone density
(D) Cause weight gain
Rationale: Phytoestrogens are plant-derived compounds that can mimic
estrogen and may help alleviate menopausal symptoms.
19. Which of the following is a contraindication for hormone replacement
therapy?
(A) Osteoporosis
2025/2026 | Comprehensive Practice Questions,
Study Guide, and Test Bank with Detailed
Rationales | Certified Menopause Practitioner
(NCMP) Review for Healthcare Professionals
1. What is the primary hormone that declines during menopause?
(A) Progesterone
(B) Estrogen
(C) Testosterone
(D) Luteinizing hormone
Rationale: Estrogen levels significantly decline during menopause, leading to
many of the symptoms associated with this transition.
2. Which of the following is a common symptom of menopause?
(A) Increased energy
(B) Hot flashes
(C) Weight loss
(D) Improved mood
Rationale: Hot flashes are a prevalent symptom experienced by many women
during menopause due to hormonal changes.
3. What is the average age of onset for menopause in women?
(A) 40
(B) 51
(C) 55
(D) 60
Rationale: The average age of menopause onset is around 51, though it can vary
from 45 to 55.
4. Which lifestyle change is recommended to manage menopausal symptoms?
(A) Increased caffeine intake
(B) Regular exercise
(C) High-fat diet
(D) Smoking cessation
Rationale: Regular exercise can help alleviate symptoms such as mood swings
and hot flashes and improve overall health.
,5. What type of therapy is often used to treat menopausal symptoms?
(A) Hormone Replacement Therapy (HRT)
(B) Antidepressants
(C) Antihistamines
(D) Antibiotics
Rationale: Hormone Replacement Therapy is a common treatment to alleviate
symptoms caused by estrogen deficiency.
6. Which of the following is a potential risk of long-term hormone replacement
therapy?
(A) Osteoporosis
(B) Breast cancer
(C) Heart disease
(D) Thyroid disorders
Rationale: Long-term use of HRT, especially combined estrogen and progestin,
has been associated with an increased risk of breast cancer.
7. What is a common non-hormonal treatment for hot flashes?
(A) Selective serotonin reuptake inhibitors (SSRIs)
(B) Beta-blockers
(C) Benzodiazepines
(D) Antihistamines
Rationale: SSRIs have been found to help reduce the frequency and severity of
hot flashes in some women.
8. Which dietary change can help manage menopausal symptoms?
(A) Increased sugar intake
(B) Increased calcium and vitamin D
(C) High caffeine consumption
(D) Low-carbohydrate diet
Rationale: Increasing calcium and vitamin D intake is crucial for bone health,
especially post-menopause, to prevent osteoporosis.
9. What is the term used to describe the time leading up to menopause?
(A) Postmenopause
(B) Perimenopause
(C) Premenopause
(D) Menopause transition
Rationale: Perimenopause refers to the transitional period leading up to
menopause, marked by hormonal fluctuations.
,10. What is a potential benefit of hormone replacement therapy?
(A) Increased risk of heart disease
(B) Relief from menopausal symptoms
(C) Weight gain
(D) Increased risk of stroke
Rationale: HRT can provide significant relief from menopausal symptoms such
as hot flashes and vaginal dryness.
11. What is the effect of menopause on bone density?
(A) Increased density
(B) Decreased density
(C) No effect
(D) Stabilized density
Rationale: The decline in estrogen levels during menopause leads to decreased
bone density, increasing the risk of osteoporosis.
12. Which of the following is a psychosocial issue that may arise during
menopause?
(A) Mood swings
(B) Improved self-esteem
(C) Increased social activity
(D) Decreased stress levels
Rationale: Many women experience mood swings and emotional changes due to
hormonal fluctuations during menopause.
13. Which of the following factors can influence the onset of menopause?
(A) Genetic predisposition
(B) Smoking
(C) All of the above
(D) None of the above
Rationale: Both genetic factors and lifestyle choices such as smoking can
influence the timing of menopause.
14. What is the primary goal of menopause management?
(A) Symptom relief
(B) Hormonal balancing
(C) Weight loss
(D) Increased libido
, Rationale: The primary goal is to relieve menopausal symptoms to improve
quality of life.
15. Which symptom is associated with decreased estrogen levels?
(A) Vaginal dryness
(B) Increased libido
(C) Improved mood
(D) Increased energy
Rationale: Decreased estrogen can lead to vaginal dryness, a common issue
during menopause.
16. What is a common urinary symptom experienced during menopause?
(A) Increased frequency
(B) Urinary incontinence
(C) Decreased frequency
(D) Painful urination
Rationale: Hormonal changes can lead to urinary incontinence, which is
common during menopause.
17. Which of the following is a potential consequence of untreated menopausal
symptoms?
(A) Improved quality of life
(B) Decreased quality of life
(C) Increased social interaction
(D) Enhanced productivity
Rationale: Untreated symptoms can lead to a lowered quality of life due to
discomfort and emotional distress.
18. What is the role of phytoestrogens in menopause management?
(A) Increase estrogen levels
(B) Mimic estrogenic activity
(C) Decrease bone density
(D) Cause weight gain
Rationale: Phytoestrogens are plant-derived compounds that can mimic
estrogen and may help alleviate menopausal symptoms.
19. Which of the following is a contraindication for hormone replacement
therapy?
(A) Osteoporosis
